⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LSTA News
Lisata Therapeutics, Inc. Common Stock
$HAREHOLDER ALERT: The M&A Class Action Firm Reminds $hareholders of Upcoming Merger Deadlines—PEN, RAPT, NATH, and LSTA
globenewswire.com
NATH
P
LSTA
RAPT
PEN
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
LSTA
RAPT
PEN
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
prnewswire.com
LSTA
NATH
RAPT
PEN
Halper Sadeh LLC Encourages SKYT, NATH, LSTA Shareholders to Contact the Firm to Discuss Their Rights
globenewswire.com
NATH
SKYT
LSTA
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—PEN, RAPT, NATH, and LSTA
globenewswire.com
NATH
P
LSTA
RAPT
PEN
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
globenewswire.com
LSTA
LSTA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Lisata Therapeutics, Inc. is Fair to Shareholders
businesswire.com
LSTA
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc.
globenewswire.com
NATH
LSTA
SNCY
VTYX
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
globenewswire.com
LSTA
Lisata Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
LSTA